XTL Biopharmaceuticals Ltd.

Regulatory Filings • Nov 25, 2014

_________ false

C007��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: -11996428Medinat hayehudim st 85 , Herzliya 4614001 , ,Tel: 09-9557080 , Fax: 09-9519727E.mail address: ir@xtlbio.comReported via MAGNA: 25/11/2014              Time of broadcast: 15:38 15:36:46

Company site:		www.xtlbio.com

Reference: 2014-02-204030

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 30/12/2014 at 11:00 the corporation will hold it's annual general meetingat Kantor & Co - Law Offices.,12 Abba Hillel Silver Road, Ramat-Gan, Israel.Number of the security that entitles its holder to vote at the meeting: 1085497The Number - as given by the Tel Aviv Stock Exchange

According to section 182 C of the Companies law, 5759-1999, only shareholders of record at the close of business 30/11/2014 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report XTL_BIOPHARMACEUTICALS_LTD_6K_isa.pdf

Attached hereto is the proxy statement EGM_Proxy_Card_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 03/09/2014
- - -
Name of the Signatory: : Kntor Ronen , Position of Signatory in the reporting corporation: Legal Adviser , Name of Employer Company: .
Abba Hillel Silver Rd Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com 2